Biomarin Pharmaceutical Inc BMRN:NASDAQ

Last Price$75.06Cboe Real-Time Last Sale as of 9:31AM ET 10/18/21
Cboe Real-Time Quotes
Realtime quote and/or trade prices are not sourced from all markets
Today's Change-0.83(1.09%)
Bid (Size)$74.67 (100)
Ask (Size)$75.35 (100)
Day Low / High$75.06 - 75.71

Sector Update: Health Care

3:35PM ET 9/07/2021 MT Newswires
Health care stocks traded above their earlier lows this afternoon, with the NYSE Health Care Index falling 0.7% while the SPDR Health Care Select Sector ETF (XLV) was down 0.6%. The Nasdaq Biotechnology index also was sinking 0.2%. In company news, BioMarin Pharmaceutical (BMRN) dropped 8.5% after saying the US Food and Drug Administration placed a clinical hold on phase I/II testing of its BMN 307 gene therapy candidate in adults with phenylketonuria after pre-clinical data showed mice treated with the highest dose of BMN 307 had liver tumors after 52 weeks.